Publication/Registration Details |
(1) 2020/39 Gaz on 2020-10-08
|
Goods & Services Limitation Details
|
Description
Class 05 -
Pharmaceutical preparations and compositions for the
treatment and prevention of cancer; pharmaceutical
preparations and substances for the prevention of cancer;
pharmaceutical products for the treatment of cancer;
pharmaceutical preparations for the treatment of
oncological, metabolic and ophthalmic diseases and
disorders; lozenges for pharmaceutical purposes for the
treatment of oncological, metabolic and ophthalmic diseases
and disorders; cachets for pharmaceutical purposes for the
treatment of oncological, metabolic and ophthalmic diseases
and disorders; biotechnological preparations for medical
purposes for the treatment of oncological, metabolic and
ophthalmic diseases and disorders; reagents for medical use;
drugs for medical purposes for the treatment of oncological,
metabolic and ophthalmic diseases and disorders; antibodies
for medical purposes for the treatment and diagnosis of
oncological, metabolic and ophthalmic diseases and
disorders; medicines for human purposes for the treatment of
oncological, metabolic and ophthalmic diseases and
disorders; anti-cancer preparations; chemically modified
antibodies for the treatment and diagnosis of oncological,
metabolic and ophthalmic diseases and disorders.
|
Publication/Registration Details |
(1) 2020/38 Gaz on 2020-10-01
|
Publication/Registration Details |
(1) 2020/3 Gaz on 2020-01-30
|
Publication/Registration Details |
(1) 2019/49 Gaz on 2019-12-19
|
Goods & Services Limitation Details
|
Description
Class 05 -
Pharmaceutical preparations and compositions for the
treatment and prevention of cancer; pharmaceutical
preparations and substances for the prevention of cancer;
pharmaceutical products for the treatment of cancer;
lozenges for pharmaceutical purposes; cachets for
pharmaceutical purposes; biotechnological preparations for
medical purposes; reagents for medical use; antibodies for
medical purposes; anti-cancer preparations; chemically
modified antibody.
|
Publication/Registration Details |
(1) 2019/50 Gaz on 2019-12-26
|
Publication/Registration Details |
(1) 2019/39 Gaz on 2019-10-10
|
Publication/Registration Details |
(1) 2019/30 Gaz on 2019-08-08
|
Designated Country Details
|
(1) CN under Protocol
(2) EM under Protocol
(3) JP under Protocol
(4) US under Protocol
|